Does CALASPARGASE PEGOL Cause Polyneuropathy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Polyneuropathy have been filed in association with CALASPARGASE PEGOL (asparlas). This represents 7.2% of all adverse event reports for CALASPARGASE PEGOL.
9
Reports of Polyneuropathy with CALASPARGASE PEGOL
7.2%
of all CALASPARGASE PEGOL reports
9
Deaths
9
Hospitalizations
How Dangerous Is Polyneuropathy From CALASPARGASE PEGOL?
Of the 9 reports, 9 (100.0%) resulted in death, 9 (100.0%) required hospitalization, and 9 (100.0%) were considered life-threatening.
Is Polyneuropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CALASPARGASE PEGOL. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CALASPARGASE PEGOL Cause?
Hypertriglyceridaemia (27)
Febrile neutropenia (19)
Hypersensitivity (13)
Neutropenia (11)
Coagulopathy (10)
Hepatotoxicity (10)
Renal failure (10)
Circulatory collapse (9)
Clostridium difficile infection (9)
Electrolyte imbalance (9)
What Other Drugs Cause Polyneuropathy?
DEXAMETHASONE (953)
BORTEZOMIB (890)
PACLITAXEL (741)
OXALIPLATIN (691)
CYCLOPHOSPHAMIDE (686)
FLUOROURACIL (525)
TRASTUZUMAB (478)
CARBOPLATIN (463)
DOXORUBICIN (452)
VINCRISTINE (440)
Which CALASPARGASE PEGOL Alternatives Have Lower Polyneuropathy Risk?
CALASPARGASE PEGOL vs CALASPARGASE PEGOL-MKNL
CALASPARGASE PEGOL vs CALCIFEDIOL
CALASPARGASE PEGOL vs CALCIPOTRIENE
CALASPARGASE PEGOL vs CALCITONIN
CALASPARGASE PEGOL vs CALCITONIN SALMON